openPR Logo
Press release

Chronic Kidney Disease Market Exponential Growth of CAGR 5.2% - Segmented By country, Top Drug Manufactures, Sales and Revenue Forecast to 2023

10-10-2018 04:23 PM CET | Health & Medicine

Press release from: Market Research Future

Chronic Kidney Disease Market

Chronic Kidney Disease Market

Market Research Future published a cooked research report on “Chronic Kidney Disease Market Research Report – By Major Industry Trends, Worldwide Business Analysis, Major Segments and Sub segments. Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Chronic Kidney Disease Market – Overview

The global chronic kidney disease market is set to expand moderately at a CAGR of 5.2% during the forecast period 2017 to 2023. The investments into development of new treatments coupled with rising prevalence of kidney diseases are expected to drive the growth of the market in the next couple of years. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the U.S., has stated that nearly 14% of the overall population is affected by chronic kidney diseases.

An upsurge in the number of biopsy procedures is witnessed in the recent times and is likely to perpetuate in the forthcoming years. This, in turn, is expected to have a positive influence on the proliferation of the chronic kidney disease market. Furthermore, the rising burden of diabetes has intensified the preventive care treatment for kidney diseases. It is anticipated to have a strong impact on the growth of the market. Other factors responsible for the growth of the market are rising healthcare expenditure, developing healthcare sector, growing research & development activities, technological advancements in the healthcare sector, etc.

Avail Premium Sample copy at https://www.marketresearchfuture.com/sample_request/5744

Chronic Kidney Disease Market – Top Players

Abbott, Siemens, Sysmex, Beckman Coulter, F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc., URIT Medical, Nova Biomedical, ARKRAY, OPTI Medical, 77 Elektronika, Randox Laboratories, Teva Pharmaceutical Industries Ltd., Amgen Inc., AstraZeneca Plc, Pfizer Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., GlaxoSmithKline Plc, AbbVie Inc., and Kissei Pharmaceutical Co. Ltd.

Industry News:

In May 2018, Baxter, a healthcare company, inked a partnership with International Society of Nephrology to advance awareness and therapy for patients with chronic kidney disease in low and middle-income countries.

In July 2018, Otsuka, a pharmaceutical company, acquired renal denervation device developed by ReCor Medical.

Global Chronic Kidney Disease Market – Regional Analysis;

The American chronic kidney disease market is driven by the increasing population with kidney diseases, extensive use of diagnostic tests for detecting kidney failure, and the increasing demand for new treatment options for kidney diseases.

In Europe, the market is driven by the growth of the medical device industry and the increasing awareness about risk factors for kidney diseases. Additionally, the increasing diabetic population and huge investments in the medical device sector by major market players also fuel the growth of the market. Germany, the largest market for chronic kidney diseases, is driven by the increasing emphasis on the development of new drugs, rising government support for research and development, and availability of funds for research.

Asia Pacific is the fastest growing chronic kidney disease market owing to the increasing prevalent diseases such as diabetes and cardiovascular diseases. Improving hospital infrastructure, the presence of skilled healthcare professionals, and rapid development in the healthcare technology are also expected to accelerate the growth of the market during the forecast period.

The Middle East and Africa hold the least share of the chronic kidney disease market due to limitations to technology and unawareness about kidney diseases and their treatments.

Get Instant Discount on Customize Report https://www.marketresearchfuture.com/check-discount/5744

Global Chronic Kidney Disease Market – Segmentation:

The global chronic kidney disease market is segmented on the basis of diagnosis, treatment, indication, and end-user. On the basis of diagnosis, it is segmented into blood test, urine test, imaging test, and kidney biopsy. On the basis of treatment, it is segmented into drugs, dialysis, and kidney transplant. Drugs are further segmented into ace inhibitors, angiotensin-ii receptor blockers, calcium channel blockers, beta-blockers, and erythropoiesis-stimulating agents. On the basis of indication, it is segmented into Type 1 or Type 2 diabetes, high blood pressure, polycystic kidney disease, and others. On the basis of end-user, it is segmented into hospitals and clinics, diagnostic centers, and others.

Ask to Our Expert at https://www.marketresearchfuture.com/enquiry/5744

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Kidney Disease Market Exponential Growth of CAGR 5.2% - Segmented By country, Top Drug Manufactures, Sales and Revenue Forecast to 2023 here

News-ID: 1294400 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Kidney

Wearable Artificial Kidney Market Development Trajectory through 2031 Dutch Kidn …
"[New York, December 2024] The Wearable Artificial Kidney represents a groundbreaking innovation in nephrology that combines advanced biomedical engineering with portable technology. Designed to continuously filter waste from the blood, this device caters primarily to patients with chronic kidney disease. As renal health issues become more prevalent globally, the relevance of the Wearable Artificial Kidney lies in its potential to enhance patient quality of life, providing a more convenient and
Kidney Dialysis Market Share Kidney Dialysis Market
According to Ameco Research 'Kidney Dialysis Market report, the analysts took this into account when estimating the Kidney Dialysis Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Kidney Dialysis Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Kidney Dialysis Market trends, segmentation, key
Kidney Health Journey: Polycystic Kidney Disease Drug Pipeline Landscape (2023-2 …
Market Outlook: The Polycystic Kidney Disease (PKD) drug pipeline landscape is poised for noteworthy advancements, offering a positive outlook for those navigating the complex journey of kidney health. As PKD poses a significant global health burden, the market outlook reflects a pressing need for innovative pharmaceutical interventions to address the challenges associated with this genetic disorder. With ongoing research and development efforts, the PKD drug pipeline is positioned to bring
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview: Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029. The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025 Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for